Matt Holt, Managing Director, joined New Mountain in 2001. He serves as the President of Private Equity and focuses on growth buyouts across a range of industries including healthcare products, health technology, materials and infrastructure. He serves as the Lead Director or Chairman of Avantor, Inc., CIOX Health, Signify Health, Cytel, emids, Ontario Systems, Revint Solutions, W20 and Zep, Inc. He also serves as a Director of Aceto, Topix Pharmaceuticals, Gelest, and TRC Companies. Mr. Holt has previously served as Lead Director of Bellerophon Therapeutics, Inc., Convey Health Solutions, Inc., Equian LLC, Ikaria, Inc., Nusil Technology LLC, and Director of MailSouth.
Mr. Holt holds an A.B. with honors in English and American Literature and Language from Harvard College in 1999.